30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

2Q13 Revenue: Medicrea

(1H13 revenue)

€11.9MM (~US $15.5MM), +10% (U.S. sales +20%)

  • Launched distribution in 4 more countries in Asia since start of year
  • Meeting with FDA by end of July regarding status of K-JAWS cervical compressive staple


2Q13 revenue: €6.6MM (~$8.7MM), +12%